TLR4 and neoplasm: Therefore, TLR4 ligands such as LPS and other modified chemical ligands [68] could be used to modify the global chromatin architecture in the tumor microenvironment and could regulate the expression of potential tumor suppressors in order to improve the overall clinical outcomes in cancer patients.